🔗 Visit the ClinicalTrials.gov page for NCT01055522
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | A dose-escalation and signal-generating study of the immunocytokine L19-IL2 in combination with dacarbazine for the therapy of patients with metastatic melanoma. | Clin Cancer Res | 2011 | 0.96 |
| 2 | Antibody-cytokine fusion proteins for treatment of cancer: engineering cytokines for improved efficacy and safety. | Semin Oncol | 2014 | 0.77 |
| 3 | Novel antibody-based proteins for cancer immunotherapy. | Cancers (Basel) | 2011 | 0.75 |